Gene · 4005
Papers2,403
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,403
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LMO2 attenuates glycolytic metabolism and facilitates cytotoxic T-lymphocyte infiltration in the tumor environment of lung and breast cancers. | Biochem Biophys Res Commun | 2023 | 37480698 | PubTator, text mining | PubMed |
| Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance. | Commun Biol | 2023 | 37479893 | PubTator, text mining | PubMed |
| The quest for the holy grail: overcoming challenges in expanding human hematopoietic stem cells for clinical use. | Stem Cell Investig | 2023 | 37457748 | PubTator, text mining | PubMed |
| Chromosome conformation capture technologies as tools to detect structural variations and their repercussion in chromatin 3D configuration. | Front Cell Dev Biol | 2023 | 37457299 | PubTator, text mining | PubMed |
| Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches. | Int J Mol Sci | 2023 | 37445860 | PubTator, text mining | PubMed |
| SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses Leukemia Growth in a T-ALL Xenotransplantation Mouse Model. | Cells | 2023 | 37443832 | PubTator, text mining | PubMed |
| The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment. | Cells | 2023 | 37443818 | PubTator, text mining | PubMed |
| SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks. | Nat Methods | 2023 | 37443338 | PubTator, text mining | PubMed |
| PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphoma. | BMC Med | 2023 | 37442994 | PubTator, text mining | PubMed |
| TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2. | Mol Cancer | 2023 | 37430263 | PubTator, text mining | PubMed |
| Identification of key biomarkers in ischemic stroke: single-cell sequencing and weighted co-expression network analysis. | Aging (Albany NY) | 2023 | 37418282 | PubTator, text mining | PubMed |
| Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies. | Biomark Res | 2023 | 37403182 | PubTator, text mining | PubMed |
| Potent and uniform fetal hemoglobin induction via base editing. | Nat Genet | 2023 | 37400614 | PubTator, text mining | PubMed |
| The Haematopoietically-expressed homeobox transcription factor: roles in development, physiology and disease. | Front Immunol | 2023 | 37398663 | PubTator, text mining | PubMed |
| A multi-omics atlas of the human retina at single-cell resolution. | Cell Genom | 2023 | 37388908 | PubTator, text mining | PubMed |
| Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth. | PLoS Biol | 2023 | 37379322 | PubTator, text mining | PubMed |
| Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy. | Front Oncol | 2023 | 37377909 | PubTator, text mining | PubMed |
| Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia. | Int J Mol Sci | 2023 | 37373496 | PubTator, text mining | PubMed |
| Spontaneous EBV-Reactivation during B Cell Differentiation as a Model for Polymorphic EBV-Driven Lymphoproliferation. | Cancers (Basel) | 2023 | 37370694 | PubTator, text mining | PubMed |
| LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer. | J Ovarian Res | 2023 | 37370140 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4005/papers?page=9